Koninklijke Philips (PHG) Income from Continuing Operations (2009 - 2026)

Koninklijke Philips' (PHG) quarterly Income from Continuing Operations came in at 273954482.12 in Q1 2026, up 98.81% year-on-year from 137796861.58 in Q1 2025, and down 68.54% quarter-over-quarter from 870704548.99 in Q4 2025.

Koninklijke Philips (PHG) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Koninklijke Philips' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 273954482.12 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 98.81% year-over-year to 273954482.12 in Q1 2026; TTM through Mar 2026 was 2198319225.45, a 22.08% decrease from a year earlier, with the FY2025 full-year figure at 1047639163.23, up 216.71% from the prior year.
  • Income from Continuing Operations eased to 273954482.12 in Q1 2026 per PHG's latest filing, from 870704548.99 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 1189960771.81 in Q2 2024 and bottomed at 1732215298.56 in Q3 2022.
  • The 5-year median for Income from Continuing Operations is 46950494.28 (2022), against an average of 120654047.76.
  • Across the five-year window, Income from Continuing Operations plunged 1231.31% in 2022 and soared 304.26% in 2024, its largest moves.
  • Year by year, Income from Continuing Operations stood at 1643618505.49 in 2022, then soared by 56.93% to 707968460.11 in 2023, then jumped by 262.56% to 1150877245.98 in 2024, then dropped by 24.34% to 870704548.99 in 2025, then slumped by 68.54% to 273954482.12 in 2026.
  • Per Business Quant, the three latest PHG Income from Continuing Operations figures stand at 273954482.12 (Q1 2026), 870704548.99 (Q4 2025), and 564653609.12 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 220.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 273.95 Mn
Dec 31, 2025 870.70 Mn
Sep 30, 2025 564.65 Mn
Jun 30, 2025 489.01 Mn
Mar 31, 2025 137.80 Mn
Dec 31, 2024 1.15 Bn
Sep 30, 2024 342.64 Mn
Jun 30, 2024 1.19 Bn
Mar 31, 2024 -857.14 Mn
Dec 31, 2023 -707.97 Mn
Sep 30, 2023 -435.44 Mn
Jun 30, 2023 -582.57 Mn
Mar 31, 2023 -743.83 Mn
Dec 31, 2022 -1.64 Bn
Sep 30, 2022 -1.73 Bn
Jun 30, 2022 -46.95 Mn
Mar 31, 2022 -320.99 Mn
Dec 31, 2021 145.28 Mn
Sep 30, 2021 304.26 Mn
Jun 30, 2021 25.29 Mn